| 注册
首页|期刊导航|临床肝胆病杂志|经肝动脉化疗栓塞术联合干扰素治疗中晚期原发性肝癌疗效的Meta分析

经肝动脉化疗栓塞术联合干扰素治疗中晚期原发性肝癌疗效的Meta分析

翁柠娜 李肖

临床肝胆病杂志Issue(1):76-79,4.
临床肝胆病杂志Issue(1):76-79,4.DOI:10.3969/j.issn.1001-5256.2016.01.012

经肝动脉化疗栓塞术联合干扰素治疗中晚期原发性肝癌疗效的Meta分析

Effect of transcatheter arterial chemoembolization combined with interferon adjuvant therapy in treatment of ad-vanced primary liver cancer:a meta-analysis

翁柠娜 1李肖2

作者信息

  • 1. 四川大学华西医院 消化科,成都610041
  • 2. 四川大学华西医院 介入诊疗中心,成都610041
  • 折叠

摘要

Abstract

Objective Toinvestigatetheeffectoftranscatheterarterialchemoembolization(TACE)combinedwithinterferon(IFN)adju-vanttherapyinthetreatmentofadvancedprimarylivercancer,andtoprovidenewideasforadjuvanttherapiesafterTACE.Methods The databases including Cochrane Library,PubMed,Medline,Embase,CNKI,Wanfang Data,and VIP were searched to obtain all articles pub-lished before January 2015,and the randomized controlled trials (RCTs)about the comparison between TACE combined with IFN and TACE alone published in journals at home and abroad were included.Quality assessment and data extraction were performed for these articles,and Revman5.1softwarewasappliedforthemeta-analysis.Results Atotalof6RCTswereincluded,consistingof311patientsintheIFN adjuvant therapy group and 308 patients in the placebo group.The results of the meta -analysis showed that compared with the placebo group,the IFN adjuvant treatment group had significantly lower 1 -,2-,and 3-year recurrence rates and a significantly higher 1 -year survivalrate(P=0.006,0.002,0.002,and0.030).Conclusion IFNadjuvanttherapycanreducetheriskoflivercancerrecurrence after TACE and improve the patients′survival rate.

关键词

肝肿瘤/化学栓塞,治疗性/干扰素类/治疗/Meta分析

Key words

liver neoplasms/chemoembolization,therapeutic/interferons/therapy/Meta-analysis

分类

医药卫生

引用本文复制引用

翁柠娜,李肖..经肝动脉化疗栓塞术联合干扰素治疗中晚期原发性肝癌疗效的Meta分析[J].临床肝胆病杂志,2016,(1):76-79,4.

基金项目

国家科学基金项目资助 ()

临床肝胆病杂志

OACSTPCD

1001-5256

访问量0
|
下载量0
段落导航相关论文